Otto Metzger, MD, is a medical oncologist specializing in breast oncology. He practices at the Breast Oncology Center at Dana-Farber/Brigham and Women’s Cancer Center and serves as an Assistant Professor of Medicine at Harvard Medical School. His clinical work centers on individualized systemic therapy, care across the metastatic and early-stage settings, and integration of novel targeted approaches into routine practice. Dr. Metzger’s research focuses on translational clinical trials, molecular profiling and longitudinal biomarker tracking to guide personalized treatment strategies, and collaborative data-sharing initiatives to accelerate therapy development. He is also committed to advancing global oncology education, having launched an international educational program supporting a network of oncology practices in Brazil, and he remains active in multidisciplinary teaching and international tumor boards. He has received the Conquer Cancer Foundation of ASCO/Breast Cancer Research Foundation Career Development Award and has been recognized for outstanding patient care. In addition to his academic role, he serves as an Executive Officer at the Alliance for Clinical Trials in Oncology, is Associate Medical Director of International Strategic Initiatives at Dana-Farber Cancer Institute, and previously chaired the Scientific Advisory Board of the Lobular Breast Cancer Alliance. He earned his MD at the Federal University of Minas Gerais in Brazil, completed residency training in Internal Medicine and Medical Oncology at the Felicio Rocho Foundation and the National Cancer Institute in Rio de Janeiro, pursued a research fellowship at Institut Jules Bordet in Brussels, and completed a Breast Oncology Fellowship at Dana-Farber Cancer Institute.
Assistant Professor
Medical School
2003
Residency
2003 – 2006
Fellowship
2006 – 2008